Daily Digest: Big Porsche hub opens in S.F.; Biotechs ink new leases
Meanwhile, a Palo Alto-based developer of immunotherapies for cardiovascular disease has just raised a $145 million in Series A.
Meanwhile, a Palo Alto-based developer of immunotherapies for cardiovascular disease has just raised a $145 million in Series A.